By using a TLR4 overexpression plasmid, we found that ruscogenin treatment potentially alleviates DSS-induced colitis in mice by inhibiting NLRP3 inflammasome activation and canonical pyroptosis, and the protective effect may be related to the suppression of the TLR4/NF-κB signaling pathway. This evidence concerns the gene TLR4 and colitis.